See where grants have been awarded across Minnesota.
The goal of this research is to facilitate the generation of human organs and cells for transplantation and repair of the human body. The generation…
2021-2023
Retinal vascular diseases, e.g., diabetic retinopathy, are a leading cause of blindness and place a significant burden on individual patients as well…
2021-2023
Cardiovascular diseases are common and deadly. It is estimated that the U.S. has limited blood supply for those that require transfusions (there are…
2021-2023
Obesity remains a significant health problem that affects above 30% of Minnesotans. Obesity increases susceptibility to injury by interfering with…
2021-2023
Neuromuscular diseases (NMDs) are life-altering conditions typically resulting in disability, poor quality of life, and eventual long-term dependency…
2021-2023
In the US, ~726,000 patients have end-stage renal disease (ESRD) requiring chronic hemodialysis, which will double in the coming decade. Optimal…
2021-2023
1. Deployment of scalable and affordable regenerative solutions for patients who have experienced heart attack.
2. Establishment of safety for a…
2021-2023
We have developed a technically simple, scalable, cGMP‐compatible method to generate hyaline cartilage from human induced pluripotent stem cells.…
2020-2021
LEAH Labs is bringing regenerative immunotherapy to dogs. We use gene editing to enable the translation of cell therapies from successful…
2020-2021
We have seven specific milestones with the goal of making bone morphogenetic protein and fibronectin (used to promote bone repair) that is…
2020-2021
We have developed a technically simple, scalable, cGMP‐compatible method to generate hyaline cartilage from human induced pluripotent stem cells.…
2020-2021
We are proposing the development of an airway cell sprayer that would be included in the instrument channel of a bronchoscope for depositing viable…
2020-2021